Jerel Davis

Jerel Davis is listed in filings as Director at Turnstone Biologics Corp.. This profile follows SEC Form 4 activity through Aug 8, 2025, including 1 public disclosure. Recent filings connect the profile to Turnstone Biologics Corp. (TSBX). The current snapshot covers public activity from Aug 8, 2025. Reported amounts are shown as $27.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.